66 results on '"G. Burrafato"'
Search Results
2. Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer
- Author
-
Vincenzo Fontana, Carlo Genova, Alberto Ballestrero, G. Burrafato, Francesco Grossi, Erika Rijavec, Claudio Sini, Angela Alama, Simona Coco, Silvia Bonfiglio, Sandra Salvi, Luca Longo, Maria Giovanna Dal Bello, Franca Carli, Giulia Barletta, Simona Boccardo, Zita Cavalieri, Marco Mora, Federica Biello, and Irene Vanni
- Subjects
Adult ,0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Lung cancer risk ,Lung Neoplasms ,DNA Repair ,medicine.medical_treatment ,Estrogen receptor ,Breast Neoplasms ,DNA-repair pathway ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Tubulin ,Internal medicine ,medicine ,Humans ,skin and connective tissue diseases ,Lung cancer ,Hormonal asset ,BRCA2 Protein ,BRCA1 Protein ,business.industry ,Cancer ,Middle Aged ,medicine.disease ,DNA-Binding Proteins ,Radiation therapy ,030104 developmental biology ,BRCA1/2 compensatory effect ,Case-Control Studies ,030220 oncology & carcinogenesis ,Concomitant ,Immunohistochemistry ,Female ,Secondary unrelated cancer ,ERCC1 ,business - Abstract
Introduction Breast cancer survivors are at increased risk of developing unrelated primary cancers, particularly lung cancer. Evidence indicates that sex hormones as well as a deregulation of DNA-repair pathways may contribute to lung cancer onset. We investigated whether the hormone status and expression of markers involved in DNA repair (BRCA1/2, ERCC1, and P53R2), synthesis (TS and RRM1), and cell division (TUBB3) might be linked to lung cancer risk. Patients and Methods Thirty-seven breast cancer survivors with unrelated lung cancer and 84 control subjects comprising women with breast cancer (42/84) or lung cancer (42/84) were enrolled. Immunohistochemistry on tumor tissue was performed. Geometric mean ratio was used to assess the association of marker levels with patient groups. Results Estrogen receptor was expressed in approximately 90% of the breast cancer group but was negative in the majority of the lung cancer group, a result similar to the lung cancer control group. Likewise, ER isoform β was weakly expressed in the lung cancer group. Protein analysis of breast cancer versus control had a significantly lower expression of BRCA1, P53R2, and TUBB3. Likewise, a BRCA1 reduction was observed in the lung cancer group concomitant with a BRCA2 increase. Furthermore, BRCA2 and TUBB3 increased in ipsilateral lung cancer in women who had previously received radiotherapy for breast cancer. Conclusion The decrease of DNA-repair proteins in breast cancer could make these women more susceptible to therapy-related cancer. The increase of BRCA2 and TUBB3 in lung cancer from patients who previously received radiotherapy for breast cancer might reflect a tissue response to exposure to ionizing radiation.
- Published
- 2020
3. EVALUATION OF CGA IMPACT ON THE QOL OF ELDERLY PATIENTS AFFECTED BY SOLID AND LIQUID MALIGNANCIES, TREATED WITH TARGET DIRECTED AGENTS OR COMPLEX MULTIMODALITY TREATMENTS
- Author
-
C. Pisani, E. Catania, Alessandra Gennari, G. Burrafato, E. Ferrara, F.Barone Adesi, Riccardo Bruna, D. Azzolina, I. Luciani, Gianluca Gaidano, M. Cappelli, and Marco Krengli
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Geriatrics and Gerontology ,business ,Multimodality - Published
- 2019
4. P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial)
- Author
-
A. Ricci, Gian Paolo Rossi, Claudia Maggioni, Luigi Cerbone, Francesco Grossi, Federica Biello, G. Burrafato, E. Rijavec, M.G. Dal Bello, A. Pezzuto, Marco Tagliamento, Claudio Sini, Simona Coco, Carlo Genova, Lodovica Zullo, A. Alama, Giulia Barletta, Simona Boccardo, E. Bennicelli, and G. Valmadre
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,business.industry ,Mutant ,Vinorelbine ,medicine.disease ,Gefitinib ,Interim ,Internal medicine ,medicine ,Non small cell ,Lung cancer ,business ,Survival analysis ,medicine.drug - Published
- 2019
5. Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer
- Author
-
Maria Di Bartolomeo, Filippo Pietrantonio, Eliana Rulli, Davide Poli, Rosa Berenato, Marta Caporale, Emilio Bajetta, Irene Floriani, E. Bajetta, M. Di Bartolomeo, L. Catena, M. Schiavo, G. Pinotti, I. Proserpio, G. Rosati, R. Bordonaro, S. Cordio, G. Burrafato, A.M. Bochicchio, M. Aieta, N. Fazio, F. Spada, V. Amoroso, G. Marini, H. Soto Parra, G. Novello, B. Massidda, M.T. Ionta, M. Comandè, R. Venezia, A. Bertolini, E. Menatti, L. Zanlorenzi, A. Colombo, A. Iop, S. Bonura, E. Mazza, M. Viganò, A. Ardizzoia, S. Dell'Oro, G. Lo Re, D. Santeufemia, A. Buonadonna, D. Luisi, G. Ucci, G. Di Lucca, A. Bonetti, F. Bergamo, M. Alù, F. Vastola, P. Marchetti, D.C. Corsi, E. Massa, G. Di Pinto, M. Duro, C. Oliani, M. Franchini, A. Inzoli, N. Gebbia, L. Repetto, S. Rota, L. Frontini, R. Labianca, S. Mosconi, A. Quadri, S. De Grossi, P. Bidoli, M.E. Cazzaniga, F. Villa, P. Foa, D. Ferrari, E. Aitini, C. Rabbi, S. Barni, F. Petrelli, M. Giordano, G. Luchena, M. Pirovano, A. Nasisi, V. Catalano, P. Giordani, A. Zaniboni, F. Leone, S. Ferrario, G.D. Beretta, E.T. Menichetti, D. Conte, D. Mari, R. Giannicola, C. Pierantoni, A.G. Luporini, A. Ragazzini, A. Ravaioli, D. Tassinari, M. Nicolini, D. Amadori, G.L. Frassineti, D. Turci, F. Zumaglini, S. Tamberi, A. Piancastelli, G. Cruciani, E. Bejtja, A. Falcone, L. Landi, G. Minuti, M. Cantore, M. Orlandi, A. Mambrini, A. Ciarlo, D. Cavaciocchi, F. Del Monte, S. Ricci, I.M. Brunetti, M. Lencioni, M. Sisani, P. Sozzi, C. Granetto, S. Chiara, A.S. Galetto, A.S. Ribecco, A. DeCensi, L. Ciuffreda, E.E. Baldini, R. Camisa, R. Todeschini, A. Santoro, L. Rimassa, C. Carnaghi, T. Pressiani, C. Boni, E. Rondini, R. Gnoni, F. Di Costanzo, S. Gasperoni, L. Cavanna, M.A. Palladino, R. Mattioli, G. Laici, F. Pucci, M.D. Alessio, I. Bernardini, G. Tomasello, G. Baldino, R. Rossetti, S. Giaquinta, C. Pinto, F. Di Fabio, F.L. Rijas Llimpe, A.A. Brandes, M. Marzola, A.O.G. Rummo Benevento, S. Competiello, V. Montesarchio, A. Rea, B. Daniele, G. Genua, M. Licenziato, R. Casaretti, L. Silvestro, M. Montano, M.G. Sarobba, G. Sanna, G. Filippelli, G. Dima, E. Greco, M. Roselli, D. Natale, G. Condemi, G. Fumi, S. Tafuto, P. Masullo, D. Nitti, A. Marchet, G. Tiberio, G. de Manzoni, S. Nobili, G. Fiorentini, R. Mazzanti, E. Perrotta, C. Carlomagno, A. De Stefano, G. Cartenì, and M. Otero
- Subjects
Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,Adjuvant chemotherapy ,medicine.medical_treatment ,Time-to-Treatment ,03 medical and health sciences ,0302 clinical medicine ,Stomach Neoplasms ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Combined Modality Therapy ,Aged ,Neoplasm Staging ,Proportional Hazards Models ,Postoperative Care ,Chemotherapy ,Proportional hazards model ,business.industry ,Stomach ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,medicine.anatomical_structure ,Chemotherapy, Adjuvant ,030220 oncology & carcinogenesis ,Adenocarcinoma ,Female ,030211 gastroenterology & hepatology ,business ,Adjuvant - Abstract
Purpose Adjuvant chemotherapy improves survival of patients with gastric cancer. Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) was a phase III study comparing sequential FOLFIRI followed by docetaxel/cisplatin versus 5-fluorouracil monotherapy. The intensive regimen was not superior in terms of disease-free survival (DFS) and overall survival (OS). Methods The treatment was to be started within 8 weeks from surgery. This analysis evaluates the impact of time from surgery to chemotherapy start (TSC) on outcomes. Results Out of 1,106 randomized, 1,072 patients without major violations of eligibility criteria and receiving at least one treatment cycle were analyzed. Median TSC was 50 days. Chemotherapy was interrupted in 201 (18.8%) cases, whereas it was completed without or with modifications in 277 (25.8%) and 594 (55.4%), respectively. At a median follow-up of 56.9 months, 513 progressions and 472 deaths occurred. A longer TSC was significantly associated with longer DFS (hazard ratio [HR] 0.95; 95% confidence interval [CI] 0.89-1.00; p = 0.05) and OS (HR 0.91; 95% CI 0.86-0.97; p = 0.004), after adjustment for treatment arm, age, sex, primary tumor site, number of resected nodes, and tumor stage. Better treatment compliance was associated with improved survival. Conclusions Our findings suggest that longer TSC had at least no detrimental effect on DFS and OS, whereas treatment completion had a protective effect. Our findings need to be confirmed prospectively.
- Published
- 2016
6. P2.03-28 Whole Exome Sequencing to Discover Lung Tumor Predisposition in Women with Previous Breast Cancer
- Author
-
Carlo Genova, Marco Mora, M.G. Dal Bello, Davide Cittaro, Federica Biello, Simona Coco, Giulia Barletta, Francesco Grossi, G. Burrafato, Claudio Sini, Gian Paolo Rossi, Silvia Bonfiglio, Simona Boccardo, A. Alama, Marco Tagliamento, Irene Vanni, Alberto Ballestrero, and E. Rijavec
- Subjects
Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,Breast cancer ,business.industry ,Internal medicine ,Medicine ,Lung tumor ,business ,medicine.disease ,Exome sequencing - Published
- 2018
7. Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy
- Author
-
Maria Giovanna Dal Bello, G. Burrafato, Francesco Grossi, Angela Alama, Claudia Maggioni, Vincenzo Fontana, Federica Biello, Carlo Genova, Irene Vanni, Giulia Barletta, Anna Truini, Erika Rijavec, Simona Coco, and Claudio Sini
- Subjects
0301 basic medicine ,Oncology ,Male ,Lung Neoplasms ,medicine.medical_treatment ,Biomarkers ,Chemotherapy ,Circulating free DNA ,Circulating tumor cells ,Liquid biopsy ,Non-small cell lung cancer (NSCLC) ,Adult ,Aged ,Tumor ,Carcinoma ,Non-Small-Cell Lung ,Cell-Free Nucleic Acids ,Cohort Studies ,Drug Therapy ,Female ,Humans ,Kaplan-Meier Estimate ,Liquid Biopsy ,Middle Aged ,Neoplastic Cells ,Circulating ,Prognosis ,Treatment Outcome ,lcsh:Chemistry ,0302 clinical medicine ,Circulating tumor cell ,Carcinoma, Non-Small-Cell Lung ,lcsh:QH301-705.5 ,Spectroscopy ,education.field_of_study ,Hazard ratio ,General Medicine ,Neoplastic Cells, Circulating ,Computer Science Applications ,Real-time polymerase chain reaction ,030220 oncology & carcinogenesis ,liquid biopsy ,circulating free DNA ,circulating tumor cells ,non-small cell lung cancer (NSCLC) ,biomarkers ,chemotherapy ,Biomarker (medicine) ,medicine.medical_specialty ,Population ,Biomarkers, Tumor ,Catalysis ,Article ,Inorganic Chemistry ,03 medical and health sciences ,Internal medicine ,medicine ,Physical and Theoretical Chemistry ,Lung cancer ,education ,Molecular Biology ,business.industry ,Organic Chemistry ,medicine.disease ,Circulating Cell-Free DNA ,030104 developmental biology ,lcsh:Biology (General) ,lcsh:QD1-999 ,business - Abstract
Cell-free DNA (cfDNA) and circulating tumor cells (CTCs) are promising prognostic and predictive biomarkers in non-small cell lung cancer (NSCLC). In this study, we examined the prognostic role of cfDNA and CTCs, in separate and joint analyses, in NSCLC patients receiving first line chemotherapy. Seventy-three patients with advanced NSCLC were enrolled in this study. CfDNA and CTC were analyzed at baseline and after two cycles of chemotherapy. Plasma cfDNA quantification was performed by quantitative PCR (qPCR) whereas CTCs were isolated by the ScreenCell Cyto (ScreenCell, Paris, France) device and enumerated according to malignant features. Patients with baseline cfDNA higher than the median value (96.3 hTERT copy number) had a significantly worse overall survival (OS) and double the risk of death (hazard ratio (HR): 2.14; 95% confidence limits (CL) = 1.24–3.68; p-value = 0.006). Conversely, an inverse relationship between CTC median baseline number (6 CTC/3 mL of blood) and OS was observed. In addition, we found that in patients reporting stable disease (SD), the baseline cfDNA and CTCs were able to discriminate patients at high risk of poor survival. cfDNA demonstrated a more reliable biomarker than CTCs in the overall population. In the subgroup of SD patients, both biomarkers identified patients at high risk of poor prognosis who might deserve additional/alternative therapeutic interventions.
- Published
- 2017
8. Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy
- Author
-
Francesco Grossi, Julia Grigorieva, G. Burrafato, Claudio Sini, Carlo Genova, Heinrich Roder, Joanna Roder, Giulia Barletta, Claudia Maggioni, M.G. Dal Bello, Erika Rijavec, Krista Meyer, and Federica Biello
- Subjects
0301 basic medicine ,Oncology ,Male ,Proteomics ,Cancer Research ,Lung Neoplasms ,medicine.medical_treatment ,cisplatin ,chemotherapy ,Carboplatin ,chemistry.chemical_compound ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,Antineoplastic Combined Chemotherapy Protocols ,VeriStrat ,80 and over ,Non-Small-Cell Lung ,Neoadjuvant therapy ,Aged, 80 and over ,non-small cell lung cancer ,biomarkers ,prognosis ,carboplatin ,pemetrexed ,Adult ,Aged ,Blood Chemical Analysis ,Cisplatin ,Female ,Humans ,Middle Aged ,Neoadjuvant Therapy ,Pemetrexed ,Predictive Value of Tests ,Prognosis ,Standard of Care ,Survival Analysis ,Hazard ratio ,030220 oncology & carcinogenesis ,Veristrat ,medicine.drug ,medicine.medical_specialty ,03 medical and health sciences ,Internal medicine ,medicine ,Lung cancer ,Carcinoma ,Survival analysis ,Chemotherapy ,business.industry ,medicine.disease ,Surgery ,030104 developmental biology ,chemistry ,Clinical Study ,business - Abstract
Background: VeriStrat is a blood-based proteomic test with predictive and prognostic significance in second-line treatments for non-small cell lung cancer (NSCLC). This trial was designed to investigate the role of VeriStrat in first-line treatment of advanced NSCLC with standard chemotherapy. Here we present the results for 76 non-squamous patients treated with a combination of carboplatin or cisplatin with pemetrexed. Methods: The test-assigned classifications of VeriStrat Good or VeriStrat Poor to samples collected at baseline. The primary end point was progression-free survival (PFS); secondary end points included overall survival (OS) and objective response. Exploratory analyses of end points separately in carboplatin/pemetrexed and cisplatin/pemetrexed subgroups were also conducted. Results: Patients classified as VeriStrat Good had longer PFS and OS than VeriStrat Poor: 6.5 vs 1.6 months and 10.8 vs 3.4 months, respectively; the corresponding hazard ratios (HRs) were 0.36 (P
- Published
- 2017
9. Oral vinorelbine in the treatment of non-small-cell lung cancer
- Author
-
Giulia Barletta, Maria Giovanna Dal Bello, G. Burrafato, Francesco Grossi, Angela Alama, Sabrina Beltramini, Simona Coco, Claudio Sini, Erika Rijavec, Anna Truini, Federica Biello, Francesco Boccardo, Irene Vanni, Carlo Genova, and Maria Attilia Grassi
- Subjects
Oncology ,medicine.medical_specialty ,Lung Neoplasms ,medicine.drug_class ,medicine.medical_treatment ,Locally advanced ,Administration, Oral ,Antineoplastic Agents ,Vinblastine ,Vinorelbine ,Vinca alkaloid ,Carcinoma, Non-Small-Cell Lung ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Lung cancer ,Randomized Controlled Trials as Topic ,Pharmacology ,Chemotherapy ,business.industry ,General Medicine ,Concurrent chemoradiation ,medicine.disease ,Treatment Outcome ,Chemotherapy, Adjuvant ,Non small cell ,business ,Adjuvant ,medicine.drug - Abstract
Originally formulated as an intravenous (i.v.) agent, vinorelbine is also currently available as an oral chemotherapeutic agent. Oral vinorelbine has demonstrated significant activity in different settings for NSCLC, including adjuvant treatment for resected disease, concurrent chemoradiation for locally advanced NSCLC and palliative chemotherapy for recurrent/metastatic NSCLC, as part of combination schedules or as a single-agent treatment.The authors explored the available data describing the use of oral vinorelbine in NSCLC. PubMed articles and abstracts presented at international conferences were analysed, and relevant trials were reported and discussed. Specific settings, including the treatment of elderly and unfit patients and metronomic schedules including oral vinorelbine, were evaluated. Available pharmacoeconomic data were also assessed.Oral vinorelbine is an appealing agent, particularly as part of combination regimens containing platinum derivatives, although it can have a role as a single-agent treatment as well. Its safety profile is generally favourable and its route of administration is generally preferred by patients receiving chemotherapy. Compared to i.v. vinorelbine and other antineoplastic agents, oral vinorelbine has been reported to be advantageous in terms of cost savings.
- Published
- 2014
10. Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy
- Author
-
Maria Giovanna Dal Bello, Anna Truini, G. Burrafato, Federica Biello, Francesco Grossi, Angela Alama, Simona Coco, Giulia Barletta, Francesco Boccardo, Carlo Genova, and Erika Rijavec
- Subjects
Oncology ,medicine.medical_specialty ,medicine.drug_class ,medicine.medical_treatment ,Clinical Biochemistry ,Antineoplastic Agents ,Ipilimumab ,Monoclonal antibody ,Immune system ,Antigen ,Carcinoma, Non-Small-Cell Lung ,Internal medicine ,Drug Discovery ,medicine ,Humans ,Immunologic Factors ,CTLA-4 Antigen ,Lung cancer ,Pharmacology ,business.industry ,Antibodies, Monoclonal ,Immunotherapy ,medicine.disease ,Small Cell Lung Carcinoma ,Clinical trial ,Immunology ,business ,medicine.drug - Abstract
Introduction: Despite recent advances with new chemotherapeutic agents and target therapies, the prognosis of NSCLC remains poor. Recent results from clinical trials of immunotherapeutic agents, especially with immune checkpoint inhibitors, make this approach very exciting in NSCLC. Ipilimumab is a monoclonal antibody directed against cytotoxic T-lymphocyte antigen 4 that is able to stimulate the antitumour immune response by promoting T-cell activation. Areas covered: We have reviewed the literature and have described the most important results obtained with ipilimumab in NSCLC in recent trials with a specific focus on its peculiar toxicity profile and pattern of response. Trials ongoing with ipilimumab are also reported. Expert opinion: The results from clinical trials with ipilimumab are promising. Some important issues in the near future will be to identify prognostic and predictive biomarkers to select patients who could benefit from this drug. Further studies are warranted to understand how to combi...
- Published
- 2014
11. Combined Water/Sand Control Polymer Treatments in Offshore Gas Wells
- Author
-
G.. Caremi, A. Zaitoun, G.. Burrafato, J. Bouillot, and G.. Dupuis
- Subjects
020401 chemical engineering ,Petroleum engineering ,Submarine pipeline ,02 engineering and technology ,0204 chemical engineering ,010502 geochemistry & geophysics ,01 natural sciences ,Geology ,0105 earth and related environmental sciences - Abstract
An original polymer technology, successfully used in Underground Gas Storage (UGS) wells, has been recently applied in offshore gas producing wells. Many gas wells in this area are facing combined water and sand problems due to reservoir depletion, water entries and clayey formation. To avoid critical problems connected to water/sand production, the most common action has been so far to reduce gas production by choking down the wells. The new technique consists of bullhead injection of water soluble polymers with the main objective to form an adsorbed polymer layer on the surface of the rock, thus providing stabilization. In addition, the products have RPM properties (Relative Permeability Modifiers). They have little impact on gas permeability while strongly reducing water permeability. The combination of both effects will result in a reduction of water and sand production. Laboratory studies were performed to optimize polymer formulation and evaluate flow properties in reservoir cores. Because of the low reservoir rock permeability (around 10-20 mD), high focus was put on polymer injectivity and RPM effects. Since 2013, nine offshore gas wells have been treated with polymers. Treatments have shown positive results combining gas rate increase up to 100% and water reduction around 50% while stopping the sand. Details regarding well and polymer selection, job design, execution and production data are provided.
- Published
- 2016
12. Fibroblast Growth Factor Receptor (FGFR): A New Target for Non-small Cell Lung Cancer Therapy
- Author
-
Federica Biello, Anna Truini, G. Burrafato, Maria Giovanna Dal Bello, Erika Rijavec, Giulia Barletta, Francesco Grossi, Angela Alama, Francesco Boccardo, Carlo Genova, and Simona Coco
- Subjects
musculoskeletal diseases ,0301 basic medicine ,Cancer Research ,Lung Neoplasms ,animal structures ,Cell ,fifbroblast growth factor receptor (FGFR) ,non-small cell lung cancer (NSCLC) ,non-small-cell lung cancer (NSCLC) ,Antineoplastic Agents ,amplification ,Fibroblast growth factor ,Bioinformatics ,FGFR Gene Amplification ,tumorigenic role ,Small Molecule Libraries ,03 medical and health sciences ,0302 clinical medicine ,Carcinoma, Non-Small-Cell Lung ,medicine ,Animals ,Humans ,Molecular Targeted Therapy ,Receptor ,Lung cancer ,Lung ,Protein Kinase Inhibitors ,Pharmacology ,prognostic role ,business.industry ,targeted inhibitors ,Antibodies, Monoclonal ,Cancer ,fifbroblast growth factor receptor (FGFR), non-small-cell lung cancer (NSCLC), amplification, tumorigenic role, prognostic role, targeted inhibitors ,medicine.disease ,Receptors, Fibroblast Growth Factor ,030104 developmental biology ,medicine.anatomical_structure ,Fibroblast growth factor receptor ,030220 oncology & carcinogenesis ,embryonic structures ,Cancer research ,Molecular Medicine ,biological phenomena, cell phenomena, and immunity ,business ,Signal Transduction - Abstract
Lung cancer is still the leading cause of cancer related death worldwide. Fibroblast growth factor receptor (FGFR) is a tirosine-kinase receptor that is seen to be amplified or mutated in non-small cell lung cancer (NSCLC) and it plays a crucial role in tumour development and maintenance. The authors analyzed the state of the art of FGFR by reviewing the current literature. Fibroblast growth factor (FGF)-FGFR pathway and their aberrations are described, with the evaluation of their possible prognostic role in NSCLC and in particular in squamous cell carcinomas, in which FGFR is more often amplified. New therapeutic agents targeting FGFR signaling have been developed and are now in clinical evaluation. Dysregulation of FGF signaling in tumour cells is related to FGFR gene amplification or mutation, although it is still uncertain which of these aberrations represents a real predictor of response to specific inhibitors. However, recent evidence has questioned whether FGFR is a real target in squamous cell histology. The effectiveness of FGFR inhibitors is also still unclear since there are no clinical data on selected patients. Moreover, the management of specific side effects related to inhibition of the physiological role of FGF should be more thorough.
- Published
- 2016
13. 3D dosimetry on Ru-106 plaque for ocular melanoma treatments
- Author
-
Giuseppe Stella, Giovanni Mannino, F. Pansini, G. Asero, N. Longhitano, R De Vincolis, A. Gueli, S. O. Troja, G. Burrafato, Catriel Greco, and A. Occhipinti
- Subjects
Radiation ,Materials science ,business.industry ,medicine.medical_treatment ,Brachytherapy ,Ocular Melanoma ,Monte Carlo method ,Dose profile ,Imaging phantom ,Calibration ,medicine ,Dosimetry ,Radiation treatment planning ,Nuclear medicine ,business ,Instrumentation - Abstract
For a few years at the Azienda Ospedaliero - Universitaria “Policlinico - Vittorio Emanuele” of Catania (Italy), ocular melanoma brachytherapic treatments with Ru-106 plaques have been made. This type of treatment is planned using the specific Treatment Planning System (TPS) BEBIG “Plaque Simulator” software that simulates the delivered dose distribution from the source used on the eye tissue. Improving dosimetry for ophthalmic therapeutic applications is worthwhile. Accurate dose measurements require detectors of adequate dimensions with respect to small distances involved. The main objective of the work is the improvement of dosimetry accuracy with a high sensitivity and spatial resolution system such as EBT2 Gafchromic ® film. The relative depth dose, the 2D and 3D distributions, the source uniformity and asymmetry were obtained using custom tissue equivalent phantom. Experimental results were compared with manufacturer’s calibration certificate data, TPS calculated values and Monte Carlo simulation results.
- Published
- 2011
14. Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine
- Author
-
Federica Biello, Francesco Boccardo, Carlo Genova, Simona Coco, Francesco Grossi, Angela Alama, Irene Vanni, Claudio Sini, Maria Giovanna Dal Bello, Erika Rijavec, G. Burrafato, Giulia Barletta, and Anna Truini
- Subjects
Lung Neoplasms ,medicine.medical_treatment ,Clinical Biochemistry ,DNA Mutational Analysis ,Disease ,Biology ,Bioinformatics ,Targeted therapy ,symbols.namesake ,Carcinoma, Non-Small-Cell Lung ,Drug Discovery ,medicine ,Humans ,Precision Medicine ,Lung cancer ,Pharmacology ,Sanger sequencing ,business.industry ,Cancer ,High-Throughput Nucleotide Sequencing ,Precision medicine ,medicine.disease ,Radiation therapy ,Drug Resistance, Neoplasm ,Mutation ,symbols ,Molecular Medicine ,Personalized medicine ,business - Abstract
Non-small cell lung cancer (NSCLC) is one of the most common causes of cancer-related death worldwide. Based on the patient's stage of disease, treatment options include surgery, radiotherapy, and chemotherapy. Although chemotherapy remains the main therapeutic approach for advanced NSCLC, targeted therapy represents a good chance of treatment for this subgroup of patients. Currently this approach is based on previous evaluation of clinically relevant mutations and the Sanger sequencing is the main approach to assign mutational status and to guide the appropriate treatment; however this tool is characterized by a low sensitivity. Recently, the advent of next-generation sequencing (NGS) has dramatically revolutionized the molecular knowledge of cancer by increasing the feasibility and possibility to sequence DNA ranging from large scale studies to targeted regions. This review reports an overview of different applications of the NGS as novel approach to study NSCLC, thereby providing information about mutational spectrum of this cancer in order to identify novel targetable mutations and to predict the emergence of drug resistance. All studies demonstrated several advantages of this approach over the traditional tools. In particular the NGS was also able to reveal mutations in low percentage, and to screen the mutational status of different critical samples such as biopsies, cytological samples and circulating plasma DNA, offering innovative diagnostic opportunities. Despite several problems have to be overcome toward the personalized therapy, the NGS represents a highly attractive system to identify mutations improving the outcome of patients with this deadly disease.
- Published
- 2015
15. ColoRaman project: Raman and fluorescence spectroscopy of oil, tempera and fresco paint pigments
- Author
-
S. O. Troja, Antonino Cosentino, G. Burrafato, M. Calabrese, A. R. Zuccarello, and Anna Maria Gueli
- Subjects
Painting ,Excitation wavelength ,Materials science ,Analytical chemistry ,Tempera ,Fluorescence ,Fluorescence spectroscopy ,symbols.namesake ,Pigment ,visual_art ,visual_art.visual_art_medium ,symbols ,General Materials Science ,Fresco ,Raman spectroscopy ,Spectroscopy - Abstract
An on-line database was compiled for the Raman and fluorescence spectra, obtained using three different excitation wavelengths (531.5, 632.8 and 780 nm), of 99 pigments analysed dry and already applied with four painting techniques (egg tempera, casein tempera, oil and fresco). The database makes it possible to determine easily the most suitable excitation wavelength for the identification of pigments already applied with these painting techniques. Copyright © 2004 John Wiley & Sons, Ltd.
- Published
- 2004
16. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
- Author
-
E. Bajetta, I. Floriani, M. Di Bartolomeo, R. Labianca, A. Falcone, F. Di Costanzo, G. Comella, D. Amadori, C. Pinto, C. Carlomagno, D. Nitti, B. Daniele, E. Mini, D. Poli, A. Santoro, S. Mosconi, R. Casaretti, C. Boni, G. Pinotti, P. Bidoli, L. Landi, G. Rosati, A. Ravaioli, M. Cantore, F. Di Fabio, E. Aitini, A. Marchet, E. Rulli, M. Cropalato Di Tullio, F. Galli, E. Biagioli, I. De Simone, S. Mangano, M. Tonato, E. Zucca, M.G. Valsecchi, S. De Placido, L. Catena, M. Schiavo, I. Proserpio, R. Bordonaro, S. Cordio, G. Burrafato, A.M. Bochicchio, M. Aieta, N. Fazio, F. Spada, V. Amoroso, G. Marini, H. Soto Parra, G. Novello, B. Massidda, M.T. Ionta, M. Comandè, R. Venezia, A. Bertolini, E. Menatti, L. Zanlorenzi, A. Colombo, A. Iop, S. Bonura, E. Mazza, M. Viganò, A. Ardizzoia, S. Dell'Oro, G. Lo Re, D. Santeufemia, A. Buonadonna, D. Luisi, G. Ucci, G. Di Lucca, A. Bonetti, F. Bergamo, M. Alù, F. Vastola, P. Marchetti, D.C. Corsi, E. Massa, G. Di Pinto, M. Duro, C. Oliani, M. Franchini, A. Inzoli, N. Gebbia, L. Repetto, S. Rota, L. Frontini, A. Quadri, S. De Grossi, M.E. Cazzaniga, F. Villa, P. Foa, D. Ferrari, C. Rabbi, S. Barni, F. Petrelli, M. Giordano, G. Luchena, M. Pirovano, A. Nasisi, V. Catalano, P. Giordani, A. Zaniboni, F. Leone, S. Ferrario, G.D. Beretta, E.T. Menichetti, D. Conte, D. Mari, R. Giannicola, C. Pierantoni, A.G. Luporini, D. Tassinari, M. Nicolini, G.L. Frassineti, D. Turci, F. Zumaglini, S. Tamberi, A. Piancastelli, G. Cruciani, G. Minuti, M. Orlandi, A. Mambrini, A. Ciarlo, D. Cavaciocchi, F. Del Monte, S. Ricci, M.I. Brunetti, M. Lencioni, M. Sisani, P. Sozzi, C. Granetto, S. Chiara, A.S. Galetto, A.S. Ribecco, A. DeCensi, L. Ciuffreda, E.E. Baldini, R. Camisa, R. Todeschini, L. Rimassa, C. Carnaghi, T. Pressiani, E. Rondini, R. Gnoni, S. Gasperoni, L. Cavanna, M.A. Palladino, R. Mattioli, G. Laici, F. Pucci, M.D. Alessio, I. Bernardini, G. Tomasello, G. Baldino, R. Rossetti, S. Giaquinta, F.L. Rijas Llimpe, A.A. Brandes, M. Marzola, V. Montesarchio, A. Rea, G. Genua, L. Silvestro, M. Montano, M.G. Sarobba, G. Sanna, G. Filippelli, G. Dima, E. Greco, M. Roselli, D. Natale, G. Condemi, G. Fumi, S. Tafuto, P. Masullo, G. Tiberio, G. de Manzoni, G. Fiorentini, R. Mazzanti, A. De Stefano, G. Cartenì, M. Otero, Bajetta, E, Floriani, I, Di Bartolomeo, M, Labianca, R, Falcone, A, Di Costanzo, F, Comella, G, Amadori, D, Pinto, C, Carlomagno, Chiara, Nitti, D, Daniele, B, Mini, E, Poli, D, Santoro, A, Mosconi, S, Casaretti, R, Boni, C, Pinotti, G, Bidoli, P, Landi, L, Rosati, G, Ravaioli, A, Cantore, M, Di Fabio, F, Marchet, A, for the ITACA S., Study Group, Carlomagno, C, Aitini, E, and Valsecchi, M
- Subjects
medicine.medical_specialty ,SURGERY ,Settore MED/06 - Oncologia Medica ,adjuvant treatment ,Docetaxel ,Gastroenterology ,LEUCOVORIN ,adjuvant chemotherapy ,gastric cancer ,Folinic acid ,Bolus (medicine) ,Stomach Neoplasms ,randomized clinical trial ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Medicine ,Humans ,GASTRECTOMY ,business.industry ,Hazard ratio ,gastric cancer, adjuvant treatment, adjuvant chemotherapy, randomized clinical trial ,PHASE-III TRIAL, CHEMOTHERAPY, SURGERY, S-1, ADENOCARCINOMA, GASTRECTOMY, LEUCOVORIN ,PHASE-III TRIAL ,ADENOCARCINOMA ,Hematology ,S-1 ,CHEMOTHERAPY ,Combined Modality Therapy ,Surgery ,Irinotecan ,Regimen ,Oncology ,Fluorouracil ,Chemotherapy, Adjuvant ,FOLFIRI ,Camptothecin ,Taxoids ,Cisplatin ,business ,medicine.drug - Abstract
Background: Some trial have demonstrated a benefit of adjuvant fluoropirimidine with or without platinum compounds compared with surgery alone. ITACA-S study was designed to evaluate whether a sequential treatment of FOLFIRI [irinotecan plus 5-fluorouracil/folinic acid (5-FU/LV)] followed by docetaxel plus cisplatin improves disease-free survival in comparison with 5-FU/LV in patients with radically resected gastric cancer. Patients and methods: Patients with resectable adenocarcinoma of the stomach or gastroesophageal junction were randomly assigned to either FOLFIRI (irinotecan 180 mg/m 2 day 1, LV 100 mg/m 2 as 2 h infusion and 5-FU 400 mg/m 2 as bolus, days 1 and 2 followed by 600 mg/m 2 /day as 22 h continuous infusion, q14 for four cycles) followed by docetaxel 75 mg/m 2 day 1, cisplatin 75 mg/m 2 day 1, q21 for three cycles (sequential arm) or De Gramont regimen (5-FU/LV arm). Results: From February 2005 to August 2009, 1106 patients were enrolled, and 1100 included in the analysis: 562 in the sequential arm and 538 in the 5-FU/LV arm. With a median follow-up of 57.4 months, 581 patients recurred or died (297 sequential arm and 284 5-FU/LV arm), and 483 died (243 and 240, respectively). No statistically significant difference was detected for both disease-free [hazard ratio (HR) 1.00; 95% confidence interval (CI): 0.85–1.17; P= 0.974] and overall survival (OS) (HR 0.98; 95% CI: 0.82–1.18; P= 0.865). Five-year disease-free and OS rates were 44.6% and 44.6%, 51.0% and 50.6% in the sequential and 5-FU/LV arm, respectively. Conclusions: A more intensive regimen failed to show any benefit in disease-free and OS versus monotherapy. Clinical trial registration: ClinicalTrials.gov Identifier: NCT01640782.
- Published
- 2014
17. Afatinib for the treatment of advanced non-small-cell lung cancer
- Author
-
Erika Rijavec, Francesco Grossi, Giulia Barletta, Simona Coco, Angela Alama, Anna Truini, G. Burrafato, Maria Giovanna Dal Bello, Francesco Boccardo, Carlo Genova, and Federica Biello
- Subjects
Oncology ,medicine.medical_specialty ,Lung Neoplasms ,Afatinib ,medicine.medical_treatment ,Antineoplastic Agents ,Pharmacology ,Disease-Free Survival ,ErbB ,Internal medicine ,Carcinoma, Non-Small-Cell Lung ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Pharmacology (medical) ,ERBB3 ,Epidermal growth factor receptor ,Lung cancer ,Adverse effect ,Protein Kinase Inhibitors ,Chemotherapy ,Clinical Trials as Topic ,biology ,business.industry ,General Medicine ,medicine.disease ,respiratory tract diseases ,ErbB Receptors ,Mutation ,biology.protein ,Quinazolines ,business ,Tyrosine kinase ,medicine.drug - Abstract
The inhibition of the epidermal growth factor receptor (EGFR) through tyrosine kinase inhibitors (TKIs) represents an effective strategy for EGFR-mutated NSCLC. Afatinib is an irreversible erythroblastosis oncogene B (ErbB) family blocker, able to inhibit the kinase domains of EGFR, HER2 and HER4, and the transphosphorylation of ErbB3 that has recently been approved in the United States for the first-line treatment of EGFR-mutated NSCLC and in Europe and Japan for the treatment of EGFR-mutated TKI-naive patients.The authors analyzed the pharmacology and the clinical activity of afatinib in NSCLC through a review of the literature. Trials exploring different settings have been reported, including LUX-Lung 3 and LUX-Lung 6, where the drug achieved better outcomes in terms of response rate, progression-free survival and quality of life compared with chemotherapy. The main toxicities of afatinib are gastrointestinal and skin-related adverse events.Afatinib showed remarkable efficacy as a first-line treatment in the presence of common EGFR mutations. Afatinib showed some activity in NSCLC with acquired resistance to EGFR TKIs, although, currently, its efficacy after the failure of erlotinib or gefitinib has not been clearly stated. Direct clinical data comparing the activity and tolerability of different inhibitors are still needed.
- Published
- 2014
18. Role of microRNAs in malignant mesothelioma
- Author
-
G. Burrafato, M.G. Dal Bello, E. Rijavec, Anna Truini, Francesco Boccardo, Carlo Genova, Giulia Barletta, Claudio Sini, Simona Coco, Francesco Grossi, and Angela Alama
- Subjects
Mesothelioma ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Biology ,medicine.disease_cause ,Genome ,Cellular and Molecular Neuroscience ,microRNA ,Gene expression ,medicine ,Biomarkers, Tumor ,Animals ,Humans ,Molecular Biology ,Gene ,Lung ,Pharmacology ,Regulation of gene expression ,Mesothelioma, Malignant ,Cancer ,Cell Biology ,Oncogenes ,medicine.disease ,Prognosis ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,Molecular Medicine ,Carcinogenesis - Abstract
Malignant mesothelioma (MM) is an aggressive tumor, mainly derived from the pleura, which is predominantly associated with exposure to asbestos fibers. The prognosis of MM patients is particularly severe, with a median survival of approximately 9-12 months and latency between exposure and diagnosis ranging from 20-50 years (median 30 years). Emerging evidence has demonstrated that tumor aggressiveness is associated with genome and gene expression abnormalities; therefore, several studies have recently focused on the role of microRNAs (miRNAs) in MM tumorigenesis. miRNAs are small non-protein coding single-stranded RNAs (17-22 nucleotides) involved in numerous cellular processes that negatively regulate gene expression by modulating the expression of downstream target genes. miRNAs are often deregulated in cancer; in particular, the differential miRNA expression profiles of MM cells compared to unaffected mesothelial cells have suggested potential roles of miRNAs as either oncogenes or tumor suppressor genes in MM oncogenesis. In this review, the mechanism of MM carcinogenesis was evaluated through the analysis of the published miRNA expression data. The roles of miRNAs as diagnostic biomarkers and prognostic factors for potential therapeutic strategies will be presented and discussed.
- Published
- 2014
19. Application of thermoluminescence to determine the presence of precursor oxides in high Tc ceramic superconductors
- Author
-
M. Russo, G. Burrafato, Anna Maria Gueli, A. Cro, L. Arcidiacono, S. O. Troja, E. Turrisi, C. Caputa, and G. Grasso
- Subjects
Superconductivity ,Nuclear and High Energy Physics ,Materials science ,Analytical chemistry ,Ceramic superconductors ,Solid-state ,Mineralogy ,Sintering ,Luminescence ,Instrumentation ,Thermoluminescence ,Stoichiometry - Abstract
The thermally stimulated luminescence of oxides, carbonates and high T C ceramic superconductors (perovskites of the (BiPb)SrCaCuO type obtained by solid state reaction) was measured in the temperature interval 20–500°C. The glow-curves obtained on the perovskites are compared with those determined for both the precursor compounds and pure (BiPb)SrCaCuO powders of the same stoichiometry. The analysis of the data evidences the possibility of characterising the oxides and carbonates and of detecting very low intensity TL signals produced in the superconductors by precursor compounds, which can be identified in some cases, and/or low amounts of semiconducting or insulating compounds probably formed during the sintering procedure.
- Published
- 1996
20. Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her2 positive metastatic breast cancer (mBC)
- Author
-
G. Burrafato, G. Lavenia, C. Martines, Roberto Bordonaro, M. Mattina, F. Latteri, P. Amadio, D. Sambataro, O. Commendatore, and P. Salice
- Subjects
Oncology ,medicine.medical_specialty ,Docetaxel ,business.industry ,Trastuzumab ,Internal medicine ,Medicine ,Hematology ,business ,medicine.disease ,Metastatic breast cancer ,medicine.drug - Published
- 2016
21. Screening of Psychological Distress in cancer patients at Oncological Reception Centre. Preliminary results
- Author
-
G. Lavenia, C. Martines, G. Burrafato, L. Longhitano, O. Commendatore, Roberto Bordonaro, Stefano Cordio, and L. Carapezza
- Subjects
medicine.medical_specialty ,Oncology ,business.industry ,medicine ,Psychological distress ,Cancer ,Hematology ,Intensive care medicine ,business ,medicine.disease ,Surgery - Published
- 2016
22. A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival
- Author
-
D. Cinà, G. Burrafato, C. Sergi, Stefano Cordio, S. Garozzo, Roberto Bordonaro, D. Sambataro, O. Commendatore, C. Martines, and S. Miraponte
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Outcome analysis ,non-small cell lung cancer (NSCLC) ,Hematology ,medicine.disease ,First line therapy ,Egfr mutation ,Internal medicine ,medicine ,business ,Tyrosine kinase - Published
- 2016
23. Efficacy of Mitomycin C plus a Fluoropyrimidine in pre-treated patients with metastatic colo-rectal cancer eligible to Regorafenib. Results of a retrospective study
- Author
-
Marco Aiello, Roberto Bordonaro, Stefano Cordio, G. Novello, Mario Uccello, M. Mattina, H. Soto-Parra, F. Martorana, G. Burrafato, Paolo Vigneri, and C. Martines
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Mitomycin C ,Retrospective cohort study ,Colo-rectal cancer ,Hematology ,chemistry.chemical_compound ,chemistry ,Regorafenib ,Internal medicine ,Medicine ,business - Published
- 2015
24. Determination of the Cation Exchange Capacity of Clays by Surface Tension Measurements
- Author
-
G. Burrafato and F. Miano
- Subjects
Chromatography ,Inorganic chemistry ,020101 civil engineering ,02 engineering and technology ,010502 geochemistry & geophysics ,01 natural sciences ,Chloride ,0201 civil engineering ,Surface tension ,chemistry.chemical_compound ,Montmorillonite ,chemistry ,Geochemistry and Petrology ,Drilling fluid ,Bentonite ,Cation-exchange capacity ,medicine ,Titration ,Clay minerals ,0105 earth and related environmental sciences ,medicine.drug - Abstract
The cation exchange capacity (CEC) of clay minerals has been determined by titration of aqueous suspension of clays with hexadecylpyridinium chloride, monitored using surface tension measurements. In order to make the method suitable for an accurate analysis of the CEC of the clays in drilling fluids or in soils, some parameters affecting the CEC determination (e.g. the presence of carboxymethylcellulose, mixing time and measurement device) have been investigated.
- Published
- 1993
25. ESR and U/Th Dating Methodologies Applied to Carbonates from Southern Italy
- Author
-
A. R. Zuccarello, A. Gueli, J. J. Bahain, Giuseppe Stella, G. Burrafato, S. O. Troja, and C. Falguères
- Subjects
Volcanic rock ,Prehistory ,geography ,geography.geographical_feature_category ,Early Pleistocene ,Stalactite ,Western europe ,Spring (hydrology) ,Context (language use) ,Archaeology ,Quartz ,Geology - Abstract
Since the dating of a stalactite from the Akiyoshi cave in Japan by Ikeya (1975), significant progress has been made in the utilisation of electron spin resonance spectroscopy (ESR) for the assessment of past radiation doses in the context of archaeological and geological dating (Rink 1997). The method is applicable to various materials such as speleothems, spring deposited travertines, mollusc shells and corals (Grun 1989). Discoveries of human remains in Western Europe have been proposed to indicate the sites of the earliest arrival of humans there, and have been dated to the Early Pleistocene by ESR using quartz and tooth enamel (Falgueres 2003). The researches based on the dating of quartz allow the age assessment of heated ceramics, volcanic rocks, intrafault material, or windblown sediments (Grun 1989). The method is also used on archaeological artefacts made of obsidian, which are precious for archaeologists, allowing them to obtain information about cultural, social and economic relations between prehistoric populations (Duttine et al. 2003).
- Published
- 2010
26. Feasibility studies for a Mediterranean neutrino observatory — the NEMO.RD Project
- Author
-
C. De Marzo, M. Ambriola, R. Bellotti, F. Cafagna, M. Calicchio, F. Ciacio, M. Circella, T. Montaruli, D. Falchieri, A. Gabrielli, E. Gandolfi, M. Masetti, C. Vitullo, G. Zanarini, R. Habel, I. Usai, S. Aiello, G. Burrafato, L. Caponetto, E. Costanzo, D. LoPresti, L. Pappalardo, C. Petta, N. Randazzo, G.V. Russo, O. Troia, R. Barnà, V. D'Amico, E. De Domenico, D. De Pasquale, S. Giacobbe, A. Italiano, F. Migliardo, G. Salvato, A. Trafirò, M. Trimarchi, F. Ameli, M. Bonori, S. Bottai, A. Capone, P. Desiati, F. Massa, R. Masullo, E. Salusti, M. Vicini, R. Coniglione, E. Migneco, P. Piattelli, R. Riccobene, P. Sapienza, M. Cordelli, L. Trasatti, V. Valente, G. De Marchis, L. Piccari, E. Accerboni, R. Mosetti, M. Astraldi, G.P. Gasparini, A. Ulzega, and P. Orrù
- Subjects
Shore ,Physics ,Nuclear and High Energy Physics ,geography ,geography.geographical_feature_category ,Detector ,Atomic and Molecular Physics, and Optics ,law.invention ,Telescope ,Data acquisition ,Software deployment ,Observatory ,law ,Systems engineering ,Underwater ,Neutrino ,Simulation - Abstract
The NEMO.RD Project is a feasibility study of a km 3 underwater telescope for high energy astrophysical neutrinos to be located in the Mediterranea Sea. At present this study concerns: i) Monte Carlo simulation study of the capabilities of various arrays of phototubes in order to determine the detector geometry that can optimize performance and cost; ii) design of low power consumption electronic cards for data acquisition and transmission to shore; iii) feasibility study of mechanics, deployment, connection and maintenance of such a detector in collaboration with petrol industries having experience of undersea operations; iv) oceanographic exploration of various sites in search for the optimal one. A brief report on the status of points i) and iv) is presented here.
- Published
- 2000
27. Influence of Pb doping on properties of BSCCO superconductor
- Author
-
G. Burrafato, E. Turrisi, C. Petta, G. Bruno, and S. O. Troja
- Subjects
chemistry.chemical_classification ,Superconductivity ,Materials science ,High-temperature superconductivity ,Doping ,Analytical chemistry ,General Physics and Astronomy ,Magnetic susceptibility ,law.invention ,chemistry ,law ,Electrical resistivity and conductivity ,Phase (matter) ,Inorganic compound ,Solid solution - Abstract
We report here about measurements of resistance vs. temperature, alternating current (a.c.) susceptibility and X-ray diffraction performed on Ba2Sr2Ca2Cu3Ox superconductor doped with various amounts of Pb. The results could be explained in terms of Pb contribution in increasing both the amount of the highest T C 0 phase and connectivity between superconductive regions. The Pb substitution on Bi sites is also discussed.
- Published
- 1991
28. Experimental TL glow curve trap parameter determination
- Author
-
F. Marzo, A. Pedalino, G. Burrafato, A. Gueli, and S.O. Troja
- Subjects
Materials science ,business.industry ,Physics::Optics ,Halide ,Kinetic energy ,Alkali metal ,Thermoluminescence ,Crystal ,Wavelength ,Optics ,Deconvolution ,Irradiation ,Atomic physics ,business - Abstract
Summary form only given. The shape of alkali halides TL glow curves can be used to calculate traps parameters from different models. Different crystals have been studied using different beta calibrated doses. All the crystals measured showed intense TL emissions hut with different behaviour and efficiency from crystal to crystal, and also of the same crystal, according to the stimulation wavelength. The peaks present in the glow-curves were analysed for a rough characterization of the crystals themselves using deconvolution of the experimental curve through a theoretical model. From the curves deconvolution we obtain, as fit parameters, information on energy trap levels and kinetic order of process. Then it is possible to compare different values calculated to the different beta doses, to evaluate the existence of an accord of the parameters value obtained on the same crystal, the eventual effect of deformations due to irradiation and the dosimetric efficiency of different alkali halides crystals.
- Published
- 2002
29. Serum Mass-Spectrometry Test in First Line Advanced Nsclc Patients Treated with Standard Chemotherapy Regimens
- Author
-
Francesco Grossi, Giulia Barletta, M.G. Dal Bello, G. Burrafato, Federica Biello, Julia Grigorieva, Krista Meyer, E. Rijavec, Claudio Sini, Carlo Genova, and Heinrich Roder
- Subjects
Oncology ,medicine.medical_specialty ,education.field_of_study ,business.industry ,Proportional hazards model ,Population ,Hazard ratio ,Hematology ,Chemotherapy regimen ,Carboplatin ,Surgery ,Exact test ,chemistry.chemical_compound ,Pemetrexed ,chemistry ,Internal medicine ,medicine ,Progression-free survival ,education ,business ,medicine.drug - Abstract
Aim: The mass-spectrometry based serum test VeriStrat□ (VS) was shown to be prognostic in various therapies and predictive of differential overall survival (OS) benefit for erlotinib vs. chemotherapy (CT) in second line NSCLC setting. Performance of the test in CT is of clinical interest. We investigated the role of VS in 1st line advanced NSCLC patients (pts) treated with Cisplatin (Cis) or Carboplatin (Carbo) plus Pemetrexed (P). Methods: VS classification was available for 55 eligible stage IV,pts with non-squamous histology; pts were classified as VS Good (VSG) or VS Poor (VSP), VS testing of pretreatment serum samples was done blinded to clinical data. OS and progression-free survival (PFS) were analyzed by Kaplan-Meier method and compared using log-rank p-values; Cox models were used in multivariate analysis. Association with categorical variables was analyzed by Fisher's exact test. Results: 36 (65%) pts were classified as VSG and 19 (35%) as VSP. In the overall population, median PFS was 5.7 months (mo) for VSG vs.1.4 mo for VSP (hazard ratio (HR) 0.37 [0.19-0.72], p = 0.002 ); adjusted HR (AHR) 0.38 [0.17-0.86], p = 0.021). Median OS was 10.8 mo for VSG vs. 3.4 mo for VSP (HR 0.23 [0.11-0.51], p Conclusions: In Platinum-based doublet CT, VSP pts had much shorter PFS and OS than VSG. The behavior was similar in CisP and CarboP arms. Further research is needed to find alternative treatments to improve outcomes for VSP pts. ClinicalTrials.gov Identifier: NCT02055144. Disclosure: J. Grigorieva: stock options of Biodesix; H. Roder: stock options of Biodesix. All other authors have declared no conflicts of interest.
- Published
- 2014
30. Serum mass-spectrometry test in first-line advanced NSCLC patients treated with standard chemotherapy regimens
- Author
-
Erika Rijavec, Julia Grigorieva, Francesco Grossi, Claudio Sini, Maria Giovanna Dal Bello, Heinrich Roder, Giulia Barletta, Federica Biello, Krista Meyer, Carlo Genova, and G. Burrafato
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Chemotherapy ,business.industry ,medicine.medical_treatment ,First line ,Surgery ,Internal medicine ,medicine ,Overall survival ,Erlotinib ,Veristrat ,business ,medicine.drug - Abstract
e19090 Background: The mass-spectrometry based serum test VeriStrat (VS) was shown to be prognostic in various therapies and predictive of differential overall survival (OS) benefit for erlotinib v...
- Published
- 2014
31. Optically stimulated luminescence dating of sediments
- Author
-
S. O. Troja, C. Amore, R. Forzese, A. Gueli, G. Barbagallo, E. Turrisi, F. Geremia, F. Marzo, G. Burrafato, M. Russo, and D. Pirnaci
- Subjects
Optically stimulated luminescence ,visual_art ,visual_art.visual_art_medium ,Infrared spectroscopy ,Mineralogy ,Dating methodologies in archaeology ,Green-light ,Luminescence ,Feldspar ,Quartz ,Geology ,Sedimentary structures - Abstract
Optically stimulated luminescence (OSL) dating methodology was applied on the coarse grain fraction (100÷500 μm thick) of quartz crystals (green light stimulated luminescence, GLSL) and feldspar crystals (infrared stimulated luminescence, IRSL) taken from sections at different depths of cores bored in various coastal lagoons (Longarini, Cuba, Bruno) in the south-east coast of Sicily. The results obtained give a sequence of congruent relative ages and maximum absolute ages compatible with the sedimentary structure, thus confirming the excellent potential of the methodology.
- Published
- 2000
32. Wellbore Stability Analysis Made Easy and Practical
- Author
-
F.J. Santarelli, S. Zaho, D. Giacca, G. Burrafato, and F. Zausa
- Subjects
Risk analysis (engineering) ,Learning curve ,Oil well ,law ,Computer science ,Drilling fluid ,Stability (learning theory) ,State of affairs ,Oil field ,Field (computer science) ,Technical progress ,law.invention - Abstract
Recent years have seen many scientific and technical progress in the field of wellbore stability understanding. The main causes of instabilities have been identified, models developed and practical remedies proposed and often tried successfully in the field. Yet despite this scientific effort, drilling extra costs associated with wellbore instabilities remain very high. This in turn demonstrates that until now, scientific and technical progress have somehow failed to reach their final technico-economical objectives. This paper shows that the main reason for such a state of affairs is the complexity of wellbore stability analysis which cannot be performed for every single well on a worldwide basis. Having identified this, Agip undertook a vast effort of field data back analysis in order to identify from historical records the best way to optimize its drilling planning, practice and post-evaluation procedures. The paper presents part of this effort and in particular the back analysis of four clusters drilled in Southern Italy -i.e. 38 wells in total. It then draws conclusions in terms of procedure optimization. Finally, it presents how the approach is used during the appraisal phase of a field in order to speed up the learning curve and hence significantly cut the development drilling costs.
- Published
- 1996
33. Nonpegylated liposome-encapsulated doxorubicin (NPLED) and cyclophosphamide in the treatment of platinum-resistant ovarian cancer: Final results of a phase II study
- Author
-
Stefania Rapisardi, Roberto Bordonaro, Salvatore Asero, Stefano Cordio, Daniela Sambataro, Concetta Di Blasi, Marco Mattina, Giuseppe Ettore, Placido Amadio, Laura Longhitano, G. Lavenia, G. Burrafato, and M Caruso
- Subjects
Cancer Research ,Cyclophosphamide ,business.industry ,Phases of clinical research ,Liposome-encapsulated doxorubicin ,chemistry.chemical_element ,Gold standard (test) ,medicine.disease ,Overall response rate ,Oncology ,chemistry ,medicine ,Cancer research ,Ovarian cancer ,business ,Platinum ,Platinum resistant ,medicine.drug - Abstract
e15544 Background: Platinum resistant-refractory ovarian cancer (PRROC) patients have a poor outcome; single-agent therapy is still the gold standard, with overall response rate lesser than 20% and progression-free-survival is not higher than 4 months. Methods: We tested safety and activity of a two-drugs-regimen containing NPLED and cyclophosphamide in a phase II open label study. From October 2007 to October 2011 thirty-two patients with platinum-resistant/refractory disease were enrolled. Enrolled patients were pretreated with a median number of 2 lines of chemotherapy, ranging from 1 to 5. NPLED and cyclophosphamide were administered at the dose of 60 mg. and 600 mg p.s.m. respectively. Results: Patients received a median number of three cycles of chemotherapy. A total of 145 cycles were administered: as G3 toxicities we registered emesis (6%), diaorrhea (3%), asthenia, and alopecia. No grade 4 adverse events occurred. Among the 30 patients evaluable for response we observed 5 (17%) partial responses and 10 (33%) stable diseases. The median progression-free-survival was 13 weeks and the median survival was 46 weeks. Conclusions: These results are similar to other data reported in literature. In conclusion we may affirm that the association of NPLED and cyclophosphamide is active and safe when administered in PRROC, but it don’t modify the prognosis of this subset of patients.
- Published
- 2012
34. Superconducting parameters of lead in Al/Formvar/Pb tunnel junctions
- Author
-
S. O. Troja, N. A. Mancini, and G. Burrafato
- Subjects
Metal ,Superconductivity ,Tunnel effect ,Amplitude ,Formvar ,Condensed matter physics ,Tunnel junction ,Phonon ,Chemistry ,visual_art ,Analytical chemistry ,visual_art.visual_art_medium ,Quantum tunnelling - Abstract
The functions Δ(ω), α 2 (ω) F(ω) and Z(ω) and the parameters λ, , μ* of Pb are calculated by analysing the tunnel characteristics of Al/Formvar/Pb junctions. The results, in comparison with those obtained on Al/Al x O y /Pb tunnel junctions, seem to exclude the direct influence of the Formvar on the electron-phonon interaction function via the transfer of vibrational structures in the explored energy range. All the observed modifications (the lowering of the amplitude of the phononic peaks of the Pb and the variation of their ratio, the reduction of λ, the negative value of (μ*) are connected with the particular structure of the insulator-superconductor interface. This interpretation is supported by the data of the ESCA analysis of the tunnel structure Les fonctions Δ(ω), α 2 (ω)F(ω), Z(ω) et les parametres λ, , μ* de Pb ont ete evalues a partir de l'analyse directe des caracteristiques tunnel de jonctions Al/Formvar/Pb
- Published
- 1984
35. Probable observation of «excitonic» superconductivity in formvar-aluminum sandwiches
- Author
-
N. A. Mancini, C. Di Mauro, Gaetano Giaquinta, F. Simone, A. Pennisi, G. Burrafato, and S. O. Troia
- Subjects
Superconductivity ,Physics ,Formvar ,Condensed matter physics ,Band gap ,Condensed Matter::Superconductivity ,Jellium ,Proximity effect (superconductivity) ,Debye frequency ,Phenomenology (psychology) ,Magnetic field - Abstract
The Ginzburg's «generalized jellium» model of the proximity effect in superconductor-dielectric systems is tested against a wide phenomenology occurring in formvar-metal multilayers. The experimental evidence gained from enhanced superconductivity, critical magnetic fields, energy gap and pair-breaking parameter values seems to support the hypothesis that a formvar eigenfrequency plays the same role as the Debye frequency in setting up the superconductivity of these systems.
- Published
- 1979
36. On the Kosterlitz-Thouless transition in dirty superconducting aluminium films of low normal state resistance
- Author
-
F. Simone, G. Burrafato, Gaetano Giaquinta, N. A. Mancini, and C. Di Mauro
- Subjects
Superconductivity ,Physics ,Kosterlitz–Thouless transition ,Condensed matter physics ,chemistry ,Aluminium ,Materials Chemistry ,Metals and Alloys ,chemistry.chemical_element ,Surfaces and Interfaces ,Normal state ,Surfaces, Coatings and Films ,Electronic, Optical and Magnetic Materials - Published
- 1981
37. Quantum size effects and transport properties in InSb thin films
- Author
-
G. Burrafato, F. Simone, N. A. Mancini, S. O. Troia, A. Pennisi, C. Di Mauro, Gaetano Giaquinta, and F. Micalizzi
- Subjects
Physics ,Condensed matter physics ,General Physics and Astronomy ,Thin film ,Quantum size - Published
- 1978
38. Influence of grain size onT c of granulated Pb films interfaced with formvar
- Author
-
G. Burrafato, S. O. Troja, and N. A. Mancini
- Subjects
Superconductivity ,Resistive touchscreen ,Formvar ,Materials science ,Transition temperature ,Analytical chemistry ,General Physics and Astronomy ,Coupling (piping) ,Vibrational spectrum ,Quantum tunnelling ,Grain size - Abstract
The behaviour of the superconducting resistive transition temperature was studied in Pb granulated filmsvs. the grain size both for films grown directly on glass and for those interfaced with Formvar. The experimental data were analysed with reference to the Garland theory as extended by Watton. An increase of the average coupling energy (ω) and a decrease of the coupling parameter (λ) were revealed in the films interfaced with Formvar. These results were correlated to the modifications of the vibrational spectrum observed, by tunnelling, in A1/Formvar/Pb junctions.
- Published
- 1982
39. On the formvar vibrational spectrum by electron tunneling
- Author
-
F. Simone, S. O. Troia, N. A. Mancini, A. Pennisi, G. Burrafato, C. Di Mauro, and Gaetano Giaquinta
- Subjects
Physics ,Formvar ,General Physics and Astronomy ,Vibrational spectrum ,Atomic physics ,Quantum tunnelling - Published
- 1977
40. Structural properties of thermal evaporated SnTe thin films
- Author
-
Alberto Torrisi, S. O. Troja, Giovanni Marletta, G. Burrafato, and E. Turrisi
- Subjects
Diffraction ,Nuclear magnetic resonance ,Materials science ,Condensed matter physics ,Electrical resistivity and conductivity ,Photoemission spectroscopy ,Thermal ,Valence band ,Energy shift ,General Physics and Astronomy ,Angle-resolved photoemission spectroscopy ,Thin film - Abstract
The morphological structure of SnTe very thin films is here studied by X-ray photoemission spectroscopy, by transmission electron spectroscopy and by X-ray diffraction. The analisys of experimental data evidences the superficial confinement of Sn, with different oxidation states, and the Te excess in the inner layers. The energy shift of the valence band peaks is attributed to modifications induced by the nonstoichiometry of the compound. Preliminary Hall and resistivity measurements seem to confirm the structural obtained results.
- Published
- 1988
41. Small influence of preparation procedures on some properties of YBa2Cu3O7−x superconductors
- Author
-
S. O. Troja, G. Bruno, E. Turrisi, and G. Burrafato
- Subjects
Superconductivity ,Diffraction ,Materials science ,Condensed matter physics ,Condensed Matter::Superconductivity ,Volume fraction ,Transition zone ,Temperature curve ,General Physics and Astronomy ,Preparation procedures ,Spectral line - Abstract
Procedures for synthesizing high-T c YBa2Cu3O7−x superconductors, alternative to the standard ones, are here studied by four-contact resistance measurementsvs. temperature and by X-ray diffraction. While X-ray spectra are consistent with the known ones, small changes in the transition temperatureT c and in shape of the resistancevs. temperature curve in the transition zone are observed. These changes could be explained in terms of volume fraction occupied by superconductive grains rather than as due to the different adopted procedures of preparation.
- Published
- 1988
42. Low-frequency phonon spectroscopy by tunnel effect
- Author
-
F. Simone, S. O. Troia, G. Burrafato, C. Di Mauro, Gaetano Giaquinta, A. Pennisi, and S. A. Mancini
- Subjects
Physics ,Tunnel effect ,Formvar ,Phonon ,Excited state ,Atomic physics ,Low frequency ,Spectroscopy ,Quantum tunnelling ,Excitation - Abstract
Low-energy structures, observed in tunnelling characteristics of Al/formvar/Sn and Al/formvar/Al junctions are reported and discussed. Their connection to tbe vibrational excitation spectrum of the insulator is indicated. Arguments are given to interpret them as excited by an inelastic tunnel mechanism of quasi-holes. A spectroscopic classification of these structures is attempted according to some results previously published. The relevance of these results, obtained for an energy range in which no data from current molecular spectroscopy are available, is stressed.
- Published
- 1977
43. Far-infra-red molecular vibrational spectroscopy by inelastic electron tunneling
- Author
-
G. Di Mauro, A. Pennisi, S. O. Troia, G. Burrafato, N. A. Mancini, C. Giaquinta, F. Simone, and F. Micalizzi
- Subjects
Physics ,Formvar ,Field (physics) ,Metallic electrode ,Infrared ,Molecular vibration ,Two-dimensional infrared spectroscopy ,General Physics and Astronomy ,Infrared spectroscopy ,Molecular physics ,Quantum tunnelling - Abstract
That an inelastic electron tunneling experiment can be a powerful tool to investigate molecular vibrational spectra was first shown by JAc~VVlC and LAMBE (1). Since that t ime much progress has been accomplished on this field: a fairly up-to-date review can be found in WOLF (2). Tunnel junctions where the insulating barrier is a thin (50--100)• film of Polyvinyl Formate have been extensively investigated by our group in the last few years (3.5). For the reader's opportunity let us briefly summarize the main results that have been obtained. First ly it was shown in (3) that, when the insulating barrier is a Formvar film, proper vibrational modes can be transferred from the metallic electrodes to the
- Published
- 1978
44. Quantum size effects and negative resistance in MOS structure with polycrystalline InSb (n-type)
- Author
-
A. Pennisi, S. O. Troja, F. Simone, N. A. Mancini, and G. Burrafato
- Subjects
Nonlinear system ,Materials science ,Semiconductor ,Condensed matter physics ,Tunnel junction ,business.industry ,Negative resistance ,Electrode ,Structure (category theory) ,General Physics and Astronomy ,Crystallite ,business ,Quantum size - Abstract
The tunnel characteristics (J vs. V) of Al−Al2O3−InSb (n type) structures with thin (100÷400)A semiconducting electrode are presented. They are analysed by utilizing the model proposed by Chang, Esaki and Styles. The data obtained by a nonlinear best fit on experimental points describe the MOS structure and the negative-resistance region exibited by the characteristics. Furthermore, the semiconductor gap shows a dependence on the thickness and this variation is explainable with the quantum effects presence in the thinnest films.
- Published
- 1982
45. Mode propagation in dirty type I superconductors well below the critical temperature
- Author
-
N. A. Mancini, F. Simone, Gaetano Giaquinta, S. O. Troia, G. Burrafato, A. Pennisi, and C. Di Mauro
- Subjects
Physics ,Superconductivity ,Solid-state physics ,Condensed matter physics ,Transition temperature ,Mode (statistics) ,General Physics and Astronomy ,Type (model theory) - Published
- 1979
46. Electrical properties of electron-gun-evaporated InAs thin films
- Author
-
Alberto Torrisi, S. Santagati, Orazio Puglisi, G. Burrafato, S.O. Troja, and N.A. Mancini
- Subjects
Materials science ,Metals and Alloys ,Analytical chemistry ,chemistry.chemical_element ,Surfaces and Interfaces ,Conductivity ,Electron spectroscopy ,Surfaces, Coatings and Films ,Electronic, Optical and Magnetic Materials ,Vacuum evaporation ,Condensed Matter::Materials Science ,chemistry ,Transmission electron microscopy ,Hall effect ,Electrical resistivity and conductivity ,Materials Chemistry ,Thin film ,Indium - Abstract
Measurements of the resistivity and the Hall coefficient versus the temperature (77–300 K) and the magnetic field (0–11 kG) were performed on InAs thin films (100–1500 A thick) obtained by vacuum evaporation from an electron gun and condensation onto glass substrates at room temperature. Analysis of the electrical results reveals the typical behaviour of disordered structures. The conductivity versus temperature curves exhibit an anomalous sharp variation which appears to separate two temperature ranges characterized by different conductivity slopes. Observation of the samples in a transmission electron microscope reveals the polycrystalline structure of the films. Electron spectroscopy for chemical analysis shows the sample to be non-stoichiometric with an excess of indium in the inner layers and the presence of indium and arsenic oxides at the surface of the films. Numerical analysis, performed with a multiparametric best-fit procedure, shows that the conductivity conforms to the percolation conductivity model but with an exponential temperature dependence, in accordance in the high temperature region with the more recent hypotheses regarding disordered structures.
- Published
- 1984
47. A remark on the superconductivity of lead in the presence of a thin formvar layer
- Author
-
C. Di Mauro, S. O. Troia, N. A. Mancini, Gaetano Giaquinta, F. Simone, A. Pennisi, and G. Burrafato
- Subjects
Physics ,Superconductivity ,Formvar ,Condensed matter physics ,Lead (sea ice) ,General Physics and Astronomy ,Layer (electronics) - Published
- 1980
48. Fluctuations of the Superconducting Order Parameter below Tc by Tunnel Effect
- Author
-
F. Simone, Gaetano Giaquinta, N. A. Mancini, A. Pennisi, S. O. Troia, and G. Burrafato
- Subjects
Physics ,Superconductivity ,Tunnel effect ,Condensed matter physics ,Transition temperature ,Champ magnetique ,Condensed Matter Physics ,Quantum tunnelling ,Electronic, Optical and Magnetic Materials ,Magnetic field - Abstract
Tunnelling anomalies in Al–formvar–Sn junctions operated at temperatures slightly below the transition temperature of the Al arm, are detected as function of externally applied magnetic fields. Evidence is given to interpret these anomalies as due to the thermodynamic fluctuations of the superconducting order parameter in the Al side. A transverse fluctuation mode appears to be present, in good agreement with the theoretical model proposed by Simanek and Hayward. Nous avons etudie le comportement anomal d'une jonction Al–formvar–Sn a une temperature peu au deseous de quelle de transition de I'electrode de Al, en fonction d'un champ magnetique applie exterieurement. On a mis en evidence I'interpretation des anomalies observees comme dues a les fluctuations thermodynamiques du parametre d'ordre du Al. Nous avons, donc, revele la presence d'un mode de fluctuation transverse, en bon accord avec le modele theorique propose de Simanek et Hayward.
- Published
- 1977
49. Electron-phonon interaction function by numerical analysis of superconducting tunnelling experimental data
- Author
-
S. O. Troja, N. A. Mancini, and G. Burrafato
- Subjects
Superconductivity ,Physics ,Condensed matter physics ,Condensed Matter::Superconductivity ,Numerical analysis ,Dispersion relation ,General Physics and Astronomy ,Superconducting tunnel junction ,Function (mathematics) ,Stability (probability) ,Integral equation ,Quantum tunnelling - Abstract
A new method of numerical analysis is presented which allows the determination of the electron-phonon interaction function α2(ω)F(ω) using the experimental data obtained from a superconducting tunnel junction. This method utilizes the dispersion relation for Δ(ω) (complex energy gap function) proposed by Galkin, D'yachenko and Svistunov. The method and the hypotheses which allow the numerical solution of the first-kind integral equation derived from the Eliashberg equations are shown and discussed. Δ(ω) and α2(ω)F(ω) of Pb are obtained by applying this method to the tunnel data of an Al−Al2O3-Pb (superconducting electrode) junction. The results are discussed with particular reference to the stability and convergence of the method applied.
- Published
- 1983
50. Influence of the properties of the materials on junction tunnelling characteristics
- Author
-
Giuseppe Faraci, N A Mancini, G. Burrafato, and Gaetano Giaquinta
- Subjects
Superconductivity ,Materials science ,Condensed matter physics ,Phonon ,General Engineering ,General Physics and Astronomy ,chemistry.chemical_element ,Dielectric ,Electron ,Condensed Matter::Mesoscopic Systems and Quantum Hall Effect ,Condensed Matter Physics ,Condensed Matter::Materials Science ,Formvar ,chemistry ,Condensed Matter::Superconductivity ,Condensed Matter::Strongly Correlated Electrons ,Tin ,Excitation ,Quantum tunnelling - Abstract
The phonon excitation spectra of Pb and Sn have been obtained from an analysis of the electron tunnel characteristics of junctions with the electrodes in the normal and the superconducting state. Metallic junctions with two different types of insulating barrier Al2O3 and Formvar, are used. The large resonant peak due to the Formvar long molecular chains has been resolved for lead. Self energy effects for the quasi-electrons in tin have been revealed and are interpreted in terms of coulombic contributions since tin is a weakly coupled electron-phonon system. Similar effects for the quasi-holes have been observed for tin in the presence of Formvar. It is also found that proper vibrations of the insulators and the metals may be reciprocally transferred.
- Published
- 1972
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.